ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 78 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,882,000 | +106.6% | 1,809,489 | +48.5% | 0.00% | +100.0% |
| Q4 2018 | $911,000 | -47.4% | 1,218,607 | +49.1% | 0.00% | -50.0% |
| Q3 2018 | $1,733,000 | -56.3% | 817,400 | -43.8% | 0.00% | 0.0% |
| Q2 2018 | $3,970,000 | +78.8% | 1,455,500 | +108.5% | 0.00% | 0.0% |
| Q1 2018 | $2,220,000 | +2.3% | 698,100 | +31.9% | 0.00% | 0.0% |
| Q4 2017 | $2,170,000 | +16.7% | 529,300 | +28.6% | 0.00% | 0.0% |
| Q3 2017 | $1,860,000 | +51.1% | 411,600 | +11.4% | 0.00% | 0.0% |
| Q2 2017 | $1,231,000 | -74.9% | 369,596 | -30.7% | 0.00% | -71.4% |
| Q1 2017 | $4,914,000 | +35.8% | 533,600 | +13.7% | 0.01% | +16.7% |
| Q4 2016 | $3,618,000 | +25.8% | 469,300 | +86.5% | 0.01% | +20.0% |
| Q3 2016 | $2,876,000 | +156.1% | 251,600 | +271.6% | 0.01% | +66.7% |
| Q3 2015 | $1,123,000 | +100.2% | 67,700 | +171.4% | 0.00% | +200.0% |
| Q2 2015 | $561,000 | +24.7% | 24,942 | +20.6% | 0.00% | 0.0% |
| Q4 2014 | $450,000 | -40.7% | 20,675 | -48.5% | 0.00% | -50.0% |
| Q3 2014 | $759,000 | -45.0% | 40,110 | -32.2% | 0.00% | -33.3% |
| Q2 2014 | $1,379,000 | – | 59,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|